Molecular Diagnostics Market Size, Opportunities, Company Profile, Developments

1. MOLECULAR DIAGNOSTICS MARKET GLOBAL ANALYSIS REPORT 2024-2030 Published by: Rahul, Marketing Head

2. Market Size & Overview: The global Molecular Diagnostics Market was valued at approximately USD 25.17 billion in 2023 and is projected to reach around USD 40.79 billion by 2030, growing at a CAGR of 7.14% during the forecast period. This market focuses on utilizing genetic and proteomic information to detect, diagnose, and monitor diseases, integrating molecular biology techniques into medical diagnostics. Key players include Roche Diagnostics, Abbott Laboratories, Thermo Fisher Scientific, and Siemens Healthineers.

3. Market Growth & Opportunities The market's expansion is primarily driven by the rising incidence of infectious diseases and cancers, along with an increased understanding and acceptance of personalized treatments. Continuous advancements in biomarker discovery and the growing demand for point- of-care diagnostics, especially highlighted during global health crises like the COVID- 19 pandemic, are further propelling market growth. Emerging economies present significant opportunities due to their increasing adoption of molecular diagnostic technologies. Sample Request Sample Request

4. Market Segmentation by Technology Polymerase Chain Reaction (PCR) Isothermal Nucleic Acid Amplification Technology (INAAT) DNA Sequencing & Next- generation Sequencing (NGS) In Situ Hybridization (ISH) DNA Microarrays Other Technologies by Product & Service Reagents & Kits Instruments Services & Software by Application Infectious Diseases Diagnostics Oncology Testing Genetic Testing Other Test Types by End User Diagnostic Laboratories Hospitals & Clinics Other by Test Type Lab Tests PoC Tests

5. Regional Analysis: • North America: Dominates the market, attributed to advanced healthcare infrastructure, significant R&D investments, and the presence of major industry players. • Europe: Holds a substantial market share, driven by supportive government initiatives, a strong focus on healthcare quality, and collaborations between research institutions and industry stakeholders. • Asia-Pacific (APAC): Expected to witness the highest growth rate, fueled by increasing healthcare expenditures, rising awareness of early disease detection, and the expansion of healthcare facilities in countries like China and India.

6. Regional Analysis Regional Analysis 2025-2030 South America Middle East and Africa North America Asia Pacific Europe Customized Report Request Customized Report Request

7. Merges and Acquisition ◦ The molecular diagnostics market has seen significant mergers and acquisitions aimed at enhancing product portfolios and expanding market reach. Notable examples include: • Roche's Acquisition of GenMark Diagnostics: In March 2021, Roche acquired GenMark Diagnostics for $1.8 billion, aiming to strengthen its molecular diagnostics capabilities. • Roche's Acquisition of TIB Molbiol: In September 2021, Roche announced the acquisition of German biotech group TIB Molbiol, enhancing its molecular diagnostics operations. Buy This Report • Roche's Acquisition of Good Therapeutics: In September 2022, Roche acquired Good Therapeutics for $250 million, focusing on advancing its PD1-regulated IL-2 receptor agonist program. Buy This Report

8. Thank You Get In Touch with US: MAXIMIZE MARKET RESEARCH PVT. LTD. 3rd Floor, Navale IT park Phase 2, Pune Banglore Highway, Narhe Pune, Maharashtra 411041, India. +91 9607365656 sales@maximizemarketresearch.com